Stage IIIB Skin Melanoma Completed Phase 1 Trials for Rasdegafusp alfa (DB15185)
| Indication | Status | Phase |
|---|---|---|
| DBCOND0029534 (Stage IIIB Skin Melanoma) | Completed | 1 |
| clinicaltrials.gov Identifier | Title | Purpose | Drugs |
|---|---|---|---|
| NCT01522820 | Vaccine Therapy With or Without Sirolimus in Treating Patients With NY-ESO-1 Expressing Solid Tumors | Treatment |